Cannabinoid Use in Special Populations

Cannabis and Pregnancy: Up in Smoke

Jocelynn Cook, PhD, MBA

Did you come across any information on the use of cannabis by males who are trying to get pregnant with their significant others, and the any effects, if any, on the fetus developmentally?

Are you aware of any ongoing or smaller studies that address the issue of dose, dose dependency and trimester of consumption?

Do you think there is any point in distinguishing between THC and CBD when we talk about cannabis use during pregnancy or breastfeeding?

Use of Cannabinoids in Older Persons

David Lussier, MD, FRCPC

What were the doses used in the Israeli and rodent studies? Are they comparable?

Allosteric Modulation of the Type 1 Cannabinoid Receptor for the Treatment of Huntington’s Disease

Robert LaPrairie, PhD

Do allosteric modulators not lead to receptor down regulation or change in receptor pool?

When you are developing the allosteric modulators, do you ever see cross stock with the CB2 receptors?

Cannabinoids in the Hospital and Long Term Care Setting

Danial Schecter, MD, CCFP

Do you prescribe cannabinoids for palliative care patients? If so, what has your experience been like?

Have you ever created education and/or a support system for nurses and other staff on medical cannabis?

What are the risks of combining cannabis with Noax for patients who have atrial fibrillation?

Did you make a full cannabinoid policy at the hospital? Would you be willing to share it?

Can patients cross the border with Sativex and Cesamet?

Is there a minimum THC level in that range of grams that you put, that you would even bother converting to Nabilone?

Challenging Patient Cases: Clinical vs. Science of Cannabis Chemovars

Caroline MacCallum, MD, FRCPC